Companies such as 23andMe and AncestryDNA offer consumers the ability to study and interpret their own genetic information--sometimes with controversial consequences. This session explores the ethical, social, and policy issues surrounding direct-to-consumer genetic testing. What conceptions of genomics are advanced by these tests? How are consumers interacting with their “raw” or uninterpreted genotype data? How can and should scientists, policymakers, and the public respond to this new era of personal genomics? Led by Sarah Nelson (Public Health Genetics).